Celltrion will look for partners in new drug development, contract manufacturing and supply chains at CPHI Worldwide in Milan (Oct 6-8).
According to The Korea Times Business, Celltrion will seek partners in new drug development, contract manufacturing, and supply chains at CPHI Worldwide in Milan from Oct. 6-8, with a focus on oncology, obesity and metabolic diseases, and autoimmune diseases. The event is in its 37th year, and over 60,000 industry professionals from about 2,400 companies in around 170 countries are expected; Celltrion will showcase its antibody drug development and manufacturing capabilities at a 152-square-meter booth.
Key facts
- 01Celltrion will participate in CPHI Worldwide in Milan from Oct. 6-8.
- 02Event is in its 37th year and expected to attract over 60,000 professionals from about 2,400 companies in 170 countries.
- 03Celltrion aims to partner in oncology, obesity/metabolic diseases, and autoimmune diseases.
- 04The company plans to emphasize antibody drug development and manufacturing capacity, plus CDMO partnerships.
- 05Booth area at the event is about 152 square meters.
AI-generated from the sources below. Always check the originals.
How each country tells it
So far our sources show coverage from one country. Perspectives appear once we find reports from a second country.
Sources
Summaries are AI-generated from the linked sources and may contain errors; always check the originals. We summarise and link; we never republish articles. Photos come from openly licensed libraries, official publicity material and brand logos, credited to their sources. If you own an image and want it credited differently or removed, email info@coda.news and we will act promptly.
- Celltrion to seek new drug, CDMO partners at int'l pharmaceutical exhibition in Milan · The Korea Times Business